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Abstract: 
 
Aim: To report clinicopathological and genomic characteristics of clear-cell papillary renal 
carcinoma (ccpRCC), a rare, recently characterized renal tumor entity.   
Methods and results: Twenty-four renal tumors identified as ccpRCC were gathered. Data 
from comparative genomic hybridization on microarrays (array-CGH) were obtained for 7 of 
them. Most tumors (58%) occurred in the absence of renal disease. Mean patient age was 58.1 
years. Tumors were small (mean size: 2.4 cm) and classified as pT1a. Histological 
characteristics consisted of tubes and papillae lined by a single layer of small clear cells 
harboring low-grade nuclei (Fuhrman grade 1 or 2). Architectural variations, with compact 
areas (41% of cases) and a micro- or macrocystic pattern (67% of cases) were frequently 
observed. Immunostaining demonstrated diffuse, strong expression of cytokeratin 7 and 
vimentin, whereas CD10, racemase, RCC antigen, TFE3 and TFEB were consistently 
negative. In 7 tumors, array-CGH detected no chromosome imbalances.  
Conclusion: ccpRCC were differentiated from other renal neoplasms by the specific 
association of histopathological and immunohistochemical features, without characteristic 
genomic imbalances. Clinical, histopathological and genomic data suggested that this tumor 
have low potential for malignancy. 
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Introduction 
 
Classification of renal epithelial neoplasms uses morphological, immunohistochemical and 
genetic features1. Accurate classification of renal tumors is critical for prognostic and 
therapeutic purposes, since new targeted therapy eligibility may rely on tumor subtype2. New 
subtypes of renal tumors have been described on the basis of their histological, 
immunophenotypic and genomic characteristics3, distinguishing them from the main subtypes 
of renal cell tumors (clear-cell renal cell carcinoma [ccRCC], papillary renal cell carcinoma 
[pRCC], chromophobe carcinoma and oncocytoma). In particular, some tumors display 
characteristics intermediate between clear-cell and papillary carcinomas4-7. In this group, 
carcinoma associated with the Xp11 translocation was individualized on the basis of a specific 
cytogenetic translocation, correlated with a specific clinical and histopathological profile8-9. In 
the remaining cases, fluorescent in situ hybridization (FISH)6,7 study or single nucleotide 
polymorphism (SNP) array10 might help to classify renal tumors.  
 
Recent studies have described clear-cell papillary renal cell carcinoma (ccpRCC) as a new 
type of renal neoplasm11-13. Clinically, it was initially observed in end-stage kidney disease11, 
but some cases have been reported in otherwise normal kidneys12-13. It presents as small renal 
tumors of low stage and low Fuhrman grade, and has a particular histological pattern 
consisting of small clear cells with tubular and papillary architecture and a specific 
imunohistochemical profile with constant expression of cytokeratin 7, whereas CD10, 
racemase and TFE3 are negative. Previously, this tumor might have been classified as clear-
cell carcinoma with papillary architecture based on cytological features, or as papillary 
carcinoma based on architectural and immunohistochemical characteristics. No loss of 
chromosome 3p and no gain of chromosomes 7 and 17 were identified by FISH13. Together, 
those data suggested that this tumor might be a specific entity in the spectrum of renal 
neoplasms12,13. However, they were based on very few studies, and no genome-wide studies 
of these tumors have been reported to our knowledge.  
 
The current study aims to identify clinical, histopathological and immunophenotypic features 
in a series of 24 ccpRCC arising in 23 patients. In addition, 7 of these tumors could be   
analyzed by comparative genomic hybridization (CGH) array. Our data confirm the clinical, 
morphological and genomic homogeneity of this subset of renal tumors and support the 
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hypothesis of the specific nature of this renal neoplasm, which differs from ccRCC and 
pRCC. 
 
Materials and methods 
 
Pathology specimens 
 
Twenty-one cases of ccpRCC were identified from cases diagnosed or addressed for 
consultation to the authors. All cases were reviewed by three pathologists (JA, MS and AV). 
Clinical data were recorded at the time of diagnosis. Tissue was obtained from nephrectomy 
(14 cases), tumorectomy (7 cases) or biopsy (1 case); specimens were fixed in formalin or 
formalin-acetic acid. Slides were examined after staining by hematein-eosin-safran. One 
paraffin-embedded block of each tumor was selected for immunohistochemical evaluation. 
Frozen tissue samples were available for CGH on microarray for 7 tumors. 
 
Immunohistochemical study 
 
Briefly, sections were cut at 4 µm from paraffin-embedded blocks, deparaffinized and 
rehydrated. Immunohistochemical staining was performed using the avidin-biotin-peroxidase 
method. Antibody references and dilutions are shown in table 1. All stainings were performed 
in a Dako Autostainer (Trappes, France) or a NexES Ventana (Illkirch, France) automated 
stainer. Immunolabellings were considered positive when diffuse strong staining was 
observed in more than 90 percent of tumor cells. Staining was considered negative if less than 
5% of tumor cells were labeled. Staining of renal parenchyma adjacent to each tumor was 
used as internal positive control for all antibodies.  
 
CGH  array 
 
Seven cases for which frozen tumor material was available were analyzed by array-CGH. All 
specimens were checked for showing more than 60% tumor cells on a frozen section prior to 
DNA extraction. Five samples were analyzed on a genome-wide 5K DNA  microarray made 
of BAC and PAC clones, with 1 Mb average resolution (CIT / INSERM U830), Hybridization 
of tumor and reference DNA   and visualization of genomic profiles  were carried out as 
previously described14. Two samples were analyzed on a NimbleGen 72K oligonucleotide 
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microarray (Roche NimbleGen, Madison WI, USA), following the procedure recommended 
by the supplier. 
 
Results 
 
Clinical findings 
 
Clinical characteristics of our patients with ccpRCC are summarized in table 2. The 
male:female gender ratio was 2.3:1. Mean age at diagnosis was 58.1 years (range: 39 to 78). 
Fourteen patients (58%) did not present any history of renal disease, nor impairment of renal 
function. In those cases, histological examination of renal parenchyma distant from the tumor 
found no evidence of associated renal disease, apart from vascular lesions and focal interstitial 
fibrosis possibly related to patient age. One patient had a history of a renal homolateral tumor 
and one presented with multiple cysts of unknown origin in both kidneys. Seven patients 
(29%) presented with end-stage kidney disease. One of them was a renal transplant recipient 
and developed a tumor on a native kidney. One patient (case no. 21) with end-stage kidney 
disease developed two metachronous ccpRCC (one on each kidney; time interval: one year). 
Two patients presented with multiple unilateral (case no. 11) or bilateral (case no. 24) small 
renal tumors identified as ccpRCC; in each case, the largest tumor was analyzed. Other 
patients presented single tumors. One patient (case no. 17; 4%) developed a tumor on an 
atrophic ectopic kidney. Clinically and radiologically, all patients were N0M0. 
 
Pathological features 
 
Macroscopically, the average size of tumors was 24 mm (range: 18 to 60 mm). They 
presented as a solid nodule slightly clearer than the adjacent renal cortical parenchyma, with 
no or very limited hemorrhagic areas and no necrotic areas. All tumors were clearly 
delineated and encapsulated. The capsule or fibrous pseudocapsule was usually thin and 
regular. Tumors exhibited a non-prominent macrocystic component. One tumor was mainly 
cystic with a small solid nodule. Adjacent parenchyma appeared either normal or abnormal   
depending on whether associated renal disease was present. 
Microscopically (table 3), all tumors showed prominent tubulo-papillary architecture, 
composed of various-sized tubes lined by a cubic epithelium. Tubes often presented abundant 
branching. Papillary projections presented either a thin or thick fibrovascular core. Cells were 
small to medium-sized, and presented optically clear cytoplasms   similar to those of clear-cell 
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carcinoma tumor cells. Nuclei were small, round, with regular borders and chromatin patterns, 
corresponding to “low-grade” nuclei (Fuhrman grade 1 or 2). Polarization of nuclei away 
from the basal pole of the cells was characteristic: nuclei were aligned in the apical pole or in 
the middle of cells, conferring an appearance similar to that of endometrial glands in early 
secretory phase. Although not observed in all areas of the tumor, this particular aspect was 
present in all cases. No area of necrosis was observed. Representative histopathological 
aspects of ccpRCC are illustrated in Figure 1A-D. 
In addition to these typical features, variations in the architectural pattern and cellular aspects 
were observed in most tumors. Architectural variations included compact areas and macro- or 
microcystic formations. Compact areas consisted of compacted tubules (easily observed after 
cytokeratin 7 immunostaining) in a scant vascular stroma, resulting in a solid appearance. 
Dilated and ramified tubules lined by cylindrical clear cells were consistently scattered 
throughout these areas. Vasculature was abundant but showed no characteristics of clear-cell 
carcinoma. Cysts were frequently observed (67% of cases). They were lined by small clear 
cells having a similar morphological aspect and immunohistochemical profile as typical areas 
of the tumor. In two tumors, cystic architecture was prominent (>50% of tumor area). On 
computed tomography evaluation, one of these cases was classified as category III according 
to the Bosniak classification. Cell variants were focal and included large cells with a clear 
cytoplasm and cells with a slightly eosinophilic cytoplasm. Stroma was fibrous and frequently 
edematous or, more rarely, focally hemorragic. All tumors were microscopically well 
delineated by a fibrous capsule or pseudocapsule of variable thickness. Pathological tumor 
stage according to WHO 2004 classification was pT1 in all cases (pT1a or pT1b depending on 
the size of the tumor).  
 
Immunohistological features 
 
Results of immunohistochemical staining are summarized in table 4 and illustrated in Figure 
1E-F. All tumors presented remarkable uniformity in their immunohistological pattern. Tumor 
cells diffusely and strongly expressed cytokeratin 7 and vimentin in all 12 cases tested. 
Expression of EMA was noted in 12/12 cases. Absence of CD10 and racemase expression 
was observed in all cases. There was no expression of RCC in 12 cases tested. 
Immunostaining for TFE3 and TFEB was negative in all cases.  
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Array-CGH analysis  
 
All 7 cases analyzed showed a flat genomic profile, with no detectable chromosome 
imbalance (Figure 1G). 
 
Discussion 
 
Most adult renal neoplasms have been characterized and classified on the basis of their 
histological, immunohistochemical and cytogenetic profiles1,3. For example, in ccRCC, loss 
of chromosome 3p leading to inactivation of the VHL gene is consistently observed, 
accompanied by alterations in other genes  15,16 ; in pRCC, trisomy 7 and 17 and other non-
random chromosomal gains are seen17,18. Recently, several rare epithelial neoplasms have 
been individualized, as their phenotypic and cytogenetic characteristics were homogenous but 
different from ccRCC and pRCC. Among these tumors, icluding TFE translocation-associated 
translocation carcinoma8 and tubulo-mucinous20 renal cell carcinoma, neither loss of 3p nor a 
gain in chromosomes 7 and 17 was observed. On the basis of cytogenetic data, these tumors 
were considered specific entities rather than variants of ccRCC or pRCC. Thus far, in most of 
these “new entities”, no specific cytogenetic abnormalities were seen. Thus, in daily practice, 
histological and immunohistochemical features remain the most pertinent elements for   
diagnosis of renal epithelial neoplasms. However, despite significant improvement in 
classification of renal epithelial neoplasms, overlapping histologic features between certain 
renal neoplasms remain,  making subclassification difficult. 
 
Renal tumors presenting with papillary architecture and clear cells are often difficult to 
classify. Some ccRCC have been shown to present papillary architecture, while others may 
present cells with clarified rather than clear cytoplasms. Some studies demonstrated that   
search for characteristic loss of 3p or chromosome 7 and 17 trisomies using FISH   or SNP-
array could enable accurately classifying many of these tumors as pRCC and ccRCC4-7,10. 
Among   remaining tumors, a new group, called ccpRCC, has recently been described. 
 
In 2006, Tickoo et al.11 described ccpRCC as a new renal neoplasm in patients with end-stage 
kidney disease. This tumor can also be observed in patients with no renal disease. In a   recent 
study, Aydin et al.13 observed that ccpRCC are small low-stage (pT1) tumors, having varying 
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but characteristic morphologic features and a characteristic immunoprofile. FISH 
demonstrated that ccpRCC does not harbor loss of 3p, nor a gain in chromosomes 7 or 17,12,13 
suggesting that this group of tumors should not be considered a morphological variant of 
ccRCC or pRCC.  
 
In our study, we collected 24 tumors from 22 patients and diagnosed them as ccpRCC;  we   
analyzed their morphologic and immunohistochemical features and, for 7 of them,   genomic 
profiles by array-CGH. This series demonstrates that ccp-RCC may occur in otherwise normal 
kidney. We confirm that variable but specific histological features characterize this tumor. 
The typical morphological aspect consists of clear cells arranged in a tubular papillary pattern 
lacking sinusoidal small vessels typical of ccRCC and foamy macrophages seen in type 1 
pRCC. Our series shows that small or large cyst formation is a frequent feature of this tumor 
and that the cystic component may sometimes be prominent. Ccp-RCC shows 
immunoreactivity to antibodies against CK7 and vimentin and lacks staining for CD10, 
AMACR (racemase) and RCC antigen. These findings are consistent with previously reported 
data12,13. 
 
Our observations led us to consider that morphologic and immunohistochemical features of 
ccpRCC distinguish this tumor from other RCC with clear-cell cytomorphology  and/or 
papillary architecture. This differential diagnosis is of particular importance for the prognosis 
linked to these entities and their eligibility for new targeted therapies, especially in ccRCC. 
This is particularly challenging, since clear-cell carcinomas may exhibit papillary or 
pseudopapillary areas, and pRCCs may contain cells with clarified cytoplasm. In contrast to 
clear-cell carcinoma, ccpRCC demonstrates a tubulo-papillary architecture. Tumor cells 
strongly express   cytokeratin 7 but do not express CD10, racemase (AMACR)  or RCC 
antigen, even in “large-cell” areas, the morphological aspect of which may be quite similar to 
ccRCC. Contrary to papillary carcinomas, ccpRCC is composed of cells with clear (optically 
“empty”) cytoplasm. In addition, tumor cells express vimentin but not racemase, a commonly 
expressed antigen in papillary carcinomas. The third differential diagnosis is TFE 
translocation-associated RCC. Although this tumor may present with clear-cell 
cytomorphology and papillary architecture, it occurs most often in young adults, is of high 
grade and demonstrates an immunohistochemical profile markedly different from that of 
ccpRCC, with expression of CD10, AMACR and TFE3 or TFEB. Thus, along with 
histological appearance, the immunohistochemical profile is particularly important for 
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distinguishing between ccpRCC,   ccRCC and pRCC. Whether ccpRCC can be observed in 
association with ccRCC or pRCC remains to be determined. None of the tumors we observed   
demonstrated such a feature. However, we observed that some ccpRCC may present small 
foci with papillary architecture and an immunoprofile similar to ccpRCC (unpublished 
observations). Thus, we suggest that a ccpRCC diagnosis should be proposed only in the 
absence of areas that can be characterized, morphologically and immunohistochemically as 
ccRCC or pRCC.  
 
Another challenging issue lies in the possibility of diagnosing ccpRCC on needle biopsy 
specimen. This technique has been shown to be accurate for diagnosis of renal tumors19. In 
one of our patients, it was possible because of the characteristic morphological aspect and 
immunohistochemical data. However, it can be difficult when confronted with compact or 
“large-cell” areas, since the morphological appearance is close to that of ccRCC. However, 
immunohistochemical studies are able to demonstrate cytokeratin 7 expression and lack of 
immunoreactivity for CD10 and racemase (AMACR) in these areas. Use of FISH has been 
recently reported and could constitute another useful tool20.  
 
To our knowledge, our study is the first array-CGH study on ccpRCC. The 7 patients 
presented a flat profile, demonstrating no genomic imbalance. This particular genomic profile 
is different from data reported in renal cell neoplasms, in particular ccRCC and pRCC. 
Indeed, these tumors nearly always present genomic imbalances, with 3p loss   observed in 
ccRCC, and gains in chromosomes 7 and 17   observed in pRCC. Though array-CGH cannot 
detect balanced chromosomal rearrangements, we cannot exclude the possibility that ccpRCC 
harbors balanced cytogenetic abnormalities. 
 
Taken together, histological observations, the immunophenotypic profile and genomic data 
suggest that ccpRCC is a specific renal neoplasm distinct from ccRCC and pRCC. Moreover, 
pT1 stage at diagnosis, the absence of vascular or perirenal extension, a histological aspect 
consistent with a “low-grade tumor” and the absence of genomic imbalance lead us to believe 
that ccpRCC have very limited (if any) potential for malignancy. In our study, we were unable 
to document follow-up of patients. The study by Aydin et al.13 reported that all 20 patients 
were disease-free at follow-up (mean: 27.4 months). The prognosis of this tumor remains to 
be characterized, in particular to determine whether some patients had metastatic disease at 
diagnosis or during follow up. 
Page 10 of 20
Published on behalf of the British Division of the International Academy of Pathology
Histopathology
For Peer Review
10 
 
 
In summary, our series demonstrates that ccpRCC can be considered   a specific type of renal 
tumor, occurring both in end-stage kidney disease and in patients with no renal disease, and 
characterized on the basis of histological, immunohistochemical and genomic features. Our 
findings highlight diagnostic criteria for ccpRCC, relying mainly on histological and 
immunohistochemical features. The current study also provides strong arguments for 
considering that this neoplasm have a low (or possibly non-existent) potential for malignancy. 
Thus, for clarity purposes, we propose naming this tumor “low-grade clear-cell papillary renal 
carcinoma” or “clear-cell papillary renal tumor”. 
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 Figure legend 
 
Figure 1. Histological, immunohistochemical and genomic features of ccpRCC. A. Typical 
histological aspect of ccpRCC: tubulo-papillary architecture with abundant branching, tubules 
lined by a single layer of small cuboid clear cells with pseudoendometrioid aspect. B. 
Compact areas: compacted tubules, scant stroma, dilated and ramified tubules lined by 
cylindric clear cells. C. Large cell areas (right of the figure). D. Edematous stroma. E. 
Cytokeratin 7 immunoreactivity in typical areas. F. Cytokeratin 7 immunoreactivity in large 
cell areas (above the figure). G. Representative array-CGH analysis of ccpRCC: no 
chromosomal imbalance could be detected. 
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Table 1: Summary of antibodies used. 
 
Antibody Clone Dilution Producer 
Cytokeratin 7 OV-TL 12/30 1:50 Dako  
Vimentin V9 1:200 Dako 
CD10 56C6 1:50 Novocastra 
Racemase (AMACR) 13H4 1:200 Dako 
TFE3 Polyclonal (P-16) 1:400 Santa Cruz 
TFEB  H-125 1:200 Santa Cruz 
Anti-RCC  marker antibody - 1:100 Dako 
EMA E29 1:100 Dako 
AMACR, alpha-methylacyl-CoA racemase ; EMA, epithelial membrane antigen. 
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Table 2: Patient characteristics. 
 
Case 
number Sex Age 
Number of 
tumors 
Renal 
function 
Associated 
renal 
disease 
Intervention 
type 
Tumor 
size 
(mm) 
TNM  stage 
(WHO 2009 
classification) 
1* M 64 1 Normal None RN 60 T1N0M0 
2 F 39 1 Normal None T 23 T1N0M0 
3* M 52 1 Normal None RN 25 T1N0M0 
4 M 55 1 Normal None T 25 T1N0M0 
5 F 78 1 Normal None T 23 T1N0M0 
6* F 45 1 Normal None RN 25 T1N0M0 
7 F 45 1 Normal None T 35 T1N0M0 
8 M 73 1 Normal None T 28 T1N0M0 
9* F 69 1 Normal None RN 25 T1N0M0 
10 M 62 1 Normal None RN Unknown T1N0M0 
11 F 60 
8 
(unilateral 
tumors) 
Normal None RN 2 to 30 T1N0M0 
12 M 42 1 Normal None Unknown Unknown T1N0M0 
13 M 69 1 Normal None T 10 T1N0M0 
14 M 48 1 Normal 
Lithiasis 
homolateral 
to tumor 
T 24 T1N0M0 
15 M 60 1 Normal Multiples 
cysts RN Unknown T1N0M0 
16* M 77 1 Impaired Unknown RN 25 T1N0M0 
17 M 63 1 Impaired Ectopic kidney RN 18 T1N0M0 
18* M 62 1 Impaired ESRD RN 15 T1N0M0 
19 Unknown 53 1 Impaired ESRD Unknown Unknown T1N0M0 
20 M 62 1 Impaired ESRD RN 13 T1N0M0 
21 M 53 2 (bilateral tumors) Impaired ESRD RN 15 et 25 T1N0M0 
22 M Unknown 1 Impaired ESRD RN 15 T1N0M0 
23* M 68 1 Impaired ESRD Unknown Unknown T1N0M0 
24 F 42 
Multiple, 
bilateral 
tumors 
 
Impaired ESRD RN <1 to 25 T1N0M0 
* Cases studied by array-CGH 
ESRD, end-stage renal disease; F, female; M, male; RN, radical nephrectomy; T, 
tumorectomy. 
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Table 3: Histological features of clear cell papillary renal cell carcinoma. 
 
Histological features Number  of cases 
Architectural features  
Tubulopapillary architecture 24/24 (100%) 
Macro- or microcystic areas 16/24 (67%) 
Compact areas  10/24 (42%) 
Prominent cystic architecture (>50% of tumor area) 2/24 (8%) 
  
Cellular features  
Cuboidal small cells with low-grade central nuclei 24/24 (100%) 
Polarization of nuclei away from basal pole (pseudoendometrial 
appearance) 
24/24 (100%) 
Foci of large cells 9/24 (38%) 
Foci of cells with slightly eosinophilic cytoplasm  2/24 (8%) 
  
Stroma  
Fibrous stroma delineating nodules 24/24 (100%) 
Edema 8/24 (33%) 
Hemorrhagic areas 1/24 (4%) 
Heterotopic bone  1/24 (4%) 
Necrosis 0/24 (0%) 
Aggregates of foamy macrophages 0/24 (0%) 
Psammomatous calcification 0/24 (0%) 
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Table 4: Immunohistological features of ccpRCC. 
 
 
Antigen Immunohistochemical staining 
Cytokeratin 7 Diffuse and intense staining in 24/24 cases  
Vimentin Diffuse staining in 12/12 cases 
CD10 No staining in 24/24 cases 
Racemase (AMACR)  No staining in 24/24 cases 
TFE3 and TFEB No staining in 12/12 cases 
RCC antigen No staining in 12/12 cases 
EMA Diffuse staining  in 12/12 cases 
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